Osteoporosis

  • Most Topular Stories

  • Research and Markets: Post Menopausal Osteoporosis - Pipeline Review, H1 2012 - SunHerald.com

    osteoporosis - Google News
    16 May 2012 | 12:04 pm
    Research and Markets: Post Menopausal Osteoporosis - Pipeline Review, H1 2012SunHerald.comDUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/lr88jn/post_menopausal_os) has announced the addition of Global Markets Direct's new report "Post Menopausal Osteoporosis - Pipeline Review, H1 2012" to their offering.and more »

  • Some Sports May Help Protect Men's Bones

    MedicineNet Osteoporosis Specialty
    15 May 2012 | 2:00 am
    Title: Some Sports May Help Protect Men's BonesCategory: Health NewsCreated: 5/14/2012 4:05:00 PMLast Editorial Review: 5/15/2012 12:00:00 AM

  • Epidemiology of fracture in the Russian Federation and the development of a FRAX model

    Archives of Osteoporosis via MedWorm.com
    8 May 2012 | 11:56 pm
    Conclusions  Fragility fractures pose a serious health care problem in Russia. Urgent steps are needed to improve the acute management of hip fracture and long-term care of other osteoporotic fractures. Content Type Journal ArticleCategory Original ArticlePages 1-7DOI 10.1007/s11657-012-0082-3Authors Olga Lesnyak, Department of Family Medicine, Ural State Medical Academy, 185, Volgogradskaya Street, Yekaterinburg, 620102 Russian FederationOlga Ershova, Department of Internal Diseases, Yaroslavl State Medical Academy, 11, Zagorodnij sad street, Yaroslavl, 150003 Russian…

  • Long-term clomiphene citrate safe in hypogonadism

    ModernMedicine - Osteoporosis
    24 Apr 2012 | 11:00 pm
    NEW YORK (Reuters Health) - Clomiphene therapy improves testosterone levels and symptoms in men with secondary hypogonadism, and a new study shows it continues to be effective and safe when given for several years.

  • gifts for kids - Yahoo! News Search Results

    fwicki masterfeed
    16 May 2012 | 9:55 am
    gifts for kids - Yahoo! News Search Results
  • add this feed to my.Alltop

    osteoporosis - Google News

  • Research and Markets: Post Menopausal Osteoporosis - Pipeline Review, H1 2012 - SunHerald.com

    16 May 2012 | 12:04 pm
    Research and Markets: Post Menopausal Osteoporosis - Pipeline Review, H1 2012SunHerald.comDUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/lr88jn/post_menopausal_os) has announced the addition of Global Markets Direct's new report "Post Menopausal Osteoporosis - Pipeline Review, H1 2012" to their offering.and more »

  • Special report: Bone densitometers - DOTmed.com

    16 May 2012 | 9:31 am
    Special report: Bone densitometersDOTmed.com dual-energy X-ray absorptiometry, or DXA, the standard test for bone mineral density, and the most accurate way to detect osteoporosis, a disease that affects an estimated 80 million women, according to the National Osteoporosis Foundation.

  • Southern Medical Association Focuses on Women's Health July 23-28, 2012 - PR Web (press release)

    16 May 2012 | 2:03 am
    Southern Medical Association Focuses on Women's Health July 23-28, 2012PR Web (press release)The two conferences, Focus on the Female Patient, July 23-26 and Osteoporosis: Diagnosis, Management and Prevention, July 26-28, offer physicians and healthcare professionals the opportunity to learn more about diagnosis, management guidelines, and more »

  • Make no bones about it: Strong bodies require the proper building blocks, the ... - Danbury News Times

    16 May 2012 | 12:17 am
    Make no bones about it: Strong bodies require the proper building blocks, the Danbury News TimesDiMarzo has osteopenia, a precursor to osteoporosis that can affect active people whose calorie/food intake is not enough for the energy they are outputting. Photo: Bob Luckey / Greenwich Time | Buy This Photo Long distance runner Mandy DiMarzo, 31, and more »

  • Playing sports bulds healthy bones - Health24.com

    15 May 2012 | 5:09 pm
    Press TVPlaying sports bulds healthy bonesHealth24.comYoung men who play load-bearing sports such as basketball and volleyball have a reduced risk of osteoporosis later in life, according to a new study. Researchers measured the bone mass of more than 800 men aged 18 to 20 and collected information about Don't be bone idle - look after your bones7DAYSSome Sports May Help Protect Men's BonesNewsday (subscription)all 11 news articles »
 
  • add this feed to my.Alltop

    Archives of Osteoporosis via MedWorm.com

  • Epidemiology of fracture in the Russian Federation and the development of a FRAX model

    8 May 2012 | 11:56 pm
    Conclusions  Fragility fractures pose a serious health care problem in Russia. Urgent steps are needed to improve the acute management of hip fracture and long-term care of other osteoporotic fractures. Content Type Journal ArticleCategory Original ArticlePages 1-7DOI 10.1007/s11657-012-0082-3Authors Olga Lesnyak, Department of Family Medicine, Ural State Medical Academy, 185, Volgogradskaya Street, Yekaterinburg, 620102 Russian FederationOlga Ershova, Department of Internal Diseases, Yaroslavl State Medical Academy, 11, Zagorodnij sad street, Yaroslavl, 150003 Russian…

  • A cohort study of osteoporosis health knowledge and medication use in older adults with minimal trauma fracture

    18 Apr 2012 | 12:21 am
    Conclusions  Osteoporosis knowledge assessed by the OKAT did not improve in the 3 months after MTF in this cohort of literate older adults, although there was some evidence of improvements in health beliefs. Current care in osteoporosis does not increase patient knowledge about their disease adequately which may impair patient effectiveness in obtaining appropriate treatment. Content Type Journal ArticleCategory Original ArticlePages 1-6DOI 10.1007/s11657-012-0084-1Authors Michele R. Levinson, Cabrini Institute, 183 Wattletree Rd, Malvern, Melbourne, VIC 3144, AustraliaTina…

  • In Memoriam: Sergio Ragi-Eis, MD

    13 Apr 2012 | 11:48 pm
    Content Type Journal ArticleCategory ObituaryPages 1-2DOI 10.1007/s11657-012-0081-4Authors Michael R. McClung, Oregon Osteoporosis Center, 5050 NE Hoyt Street Suite 626, Portland, OR 97213, USA Journal Archives of OsteoporosisOnline ISSN 1862-3514Print ISSN 1862-3522 (Source: Archives of Osteoporosis)

  • Symptoms of anxiety or depression and risk of fracture in older people: the Hertfordshire Cohort Study

    12 Apr 2012 | 12:09 am
    Conclusions  High levels of anxiety in older men may increase their risk of fracture. Future research needs to replicate this finding in other populations and investigate the underlying mechanisms. Content Type Journal ArticleCategory Original ArticlePages 1-7DOI 10.1007/s11657-012-0080-5Authors Catharine R. Gale, MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UKElaine M. Dennison, MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UKMark Edwards, MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UKAvan Aihie…

  • Functional fitness and bone mineral density in the elderly

    12 Apr 2012 | 12:09 am
    Conclusions  Sex, age, height, BM, TLTM, and TFM entered as the most significant contributors for BMD and FSI. Although FF parameters are typically considered in clinical assessments of bone health/strength in older people, body composition appears to have a higher relevance in the explanation of BMD and strength. Content Type Journal ArticleCategory Original ArticlePages 1-11DOI 10.1007/s11657-012-0083-2Authors Élvio R. Gouveia, Department of Physical Education and Sports, University of Madeira, Campus Universitário da Penteada, 9000-390 Funchal, PortugalJosé A. Maia, CIFI2D and…
 
 
  • add this feed to my.Alltop

    MarketWatch.com - All MarketWatch News - Osteoporosis

  • Warner Chilcott swings to profit as expenses fall

    4 May 2012 | 10:11 am
    Warner Chilcott PLC WCRX swung to a profit in the first quarter as reduced expenses helped offset continued revenue declines and weak sales of its key Actonel osteoporosis treatment. Results easily beat expectations, but the company lowered its guidance for the year, calling for earnings of $3.30 to $3.40 a share on revenue of $2.4 billion to $2.5 billion.

  • Allergan profit up 45% on specialty drug sales

    2 May 2012 | 10:40 am
    Allergan Inc.'s AGN first-quarter earnings rose 45% as the maker of Botox and medical devices reported double-digit sales growth at its specialty pharmaceuticals business. The company projected second-quarter results below analysts' expectations, with earnings of $1.04 to $1.06 a share on revenue of $1.45 billion to $1.5 billion.

  • FDA letter rejects expanded use of Xgeva: Amgen

    27 Apr 2012 | 7:49 am
    Amgen Inc. AMGN received a complete response letter from the U.S. Food and Drug Administration rejecting the expanded use of Xgeva in men with prostate cancer that hasn't spread to the bones. According to the drug maker, the FDA letter said the agency can't approve the supplemental biologics license application in its present form because the effect on bone metastases-free survival doesn't outweigh the risks, such as osteonecrosis of the jaw, a rare jaw-decay problem.

  • Merck profit rises 67% on lower costs

    27 Apr 2012 | 7:47 am
    Merck & Co.'s MRK first-quarter earnings rose 67% as the drug maker's cost controls helped offset slower-than-expected sales growth. Merck, like its rivals, has been cutting costs as part of an effort to soften the hit from increased generic competition. The company's top-selling allergy and asthma medication Singulair loses patent exclusivity in August and the ripple-effect from generic versions of rival Pfizer Inc.'s (PFE) cholesterol fighter Lipitor have contributed to a decline in sales of Merck's anticholesterol drug Vytorin.

  • Merck profit rises 67% on lower costs

    27 Apr 2012 | 7:43 am
    Merck & Co.'s MRK first-quarter earnings rose 67% as the drug maker's cost controls helped offset slower-than-expected sales growth. Merck, like its rivals, has been cutting costs as part of an effort to soften the hit from increased generic competition. The company's top-selling allergy and asthma medication Singulair loses patent exclusivity in August and the ripple-effect from generic versions of rival Pfizer Inc.'s (PFE) cholesterol fighter Lipitor have contributed to a decline in sales of Merck's anticholesterol drug Vytorin.
  • add this feed to my.Alltop

    Osteoporosis - Articles - Zimbio

  • TheTruthAboutOsteoporosis.com - Truth About Osteoporosis Ebook

    15 May 2012 | 5:51 pm
    TheTruthAboutOsteoporosis.com - Truth About Osteoporosis EbookWhen I first began my search, I could find little or nothing on the subject of bone loss.  Little by little I began to fit together the pieces to the puzzle.  I found highly-trained professionals who have extensive knowledge of bone health.  These are professionals who know and understand how the body works and how the body can come into a natural balance that enhances bone health.  Read More About: TheTruthAboutOsteoporosis.com - Truth About Osteoporosis Ebook   I conducted in-depth interviews with these…

  • FDA Finds Osteoporosis Drugs Not Effective Long-Term

    15 May 2012 | 5:06 pm
    Unless you’re talking about roses on Mother’s Day (hint, hint), more is not always better. Case in point: A new FDA study finds that taking anti-bone-loss drugs like Fosamax long-term isn’t all it’s cracked up to be. Read More...

  • Are Popular Osteoporosis Medications Fosamax, Boniva, Actonel and Reclast Worth Risking the Dangerous Side Effects?

    13 May 2012 | 6:18 pm
    The most popular medications osteoporosis and osteopenia are Bisphosphonates, better known as Fosamax, Boniva, Actonel and Reclast. What is unsettling about these drugs is twofold. First, they can have debilitating side effects and second, they may not be as effective as natural remedies in preventing and reversing bone loss.

  • FDA Cautions on Long Term Use of Popular Osteoporosis Drugs

    10 May 2012 | 4:00 pm
    According to recent research from the Food and Drug Administration, bone strengthening drugs such as Fosamax, Boniva, Actonel and other bisphosphonates, which are used to treat osteopenia, osteoporosis in postmenopausal women and Paget’s disease, may have little long term benefit. The findings suggest that taking the drugs for more than 3-5 years may not be helpful [...]

  • The Possibility of A New Osteoporosis Treatment

    30 Apr 2012 | 1:58 pm
    These days, people are quite interested with new treatments for osteoporosis especially that Merck has somehow got away with Fosamax lawsuits. If we are to remember, Merck & Co. received many complaints which turned into numerous lawsuits due to the adverse effects people have experienced from using the drug, which according to reports, already came into the knowledge of its manufacturer. Currently, researchers from Mount Sinai Hospital in New York are testing thyroid stimulating hormone (TSH) to possibly treat osteoporosis. TSH is a hormone produced by the anterior pituitary gland.
 
Log in